- Work address:
- Cancer Research UK Cambridge Institute University of Cambridge Li Ka Shing Centre Robinson Way Cambridge CB2 0RE
-
From a genome-wide screen of RNAi molecules against SARS-CoV-2 to a validated broad-spectrum and potent prophylaxis.
E-pub date: 16 Mar 2023Journal name: Commun Biol
Clonal transcriptomics identifies mechanisms of chemoresistance and empowers rational design of combination therapies.
E-pub date: 16 Dec 2022Journal name: Elife
Genome wide screen of RNAi molecules against SARS-CoV-2 creates a broadly potent prophylaxis
E-pub date: 12 Apr 2022Journal name:
- Research Integrity Conflict of Interest Disclosure:
- Last revised:
- 21/11/2022
Company Active Research funding Ownership Royalty payments Commitment to carry out work for a fee Ad hoc reimbursed work Travel Gifts/ other Suil Interactive Yes No Yes No No No No No Elyx Ltd Yes No Yes No No No No No Eleven Therapeutics No No Yes No Yes No No No Bit.bio No No No No Yes No No No
Tweets
© 2023 University of Cambridge
This Site Uses Cookies
We may use cookies to record some preference settings and to analyse how you use our web site. We may also use external analysis systems which may set additional cookies to perform their analysis.These cookies (and any others in use) are detailed in our site privacy and cookie policies and are integral to our web site. You can delete or disable these cookies in your web browser if you wish but then our site may not work correctly.